Unusual volume stocks in Thursday's session
By Mill Chart
Last update: May 25, 2023
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.
Unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| UTRS | -25.02% | So far 5.46M shares of MINERVA SURGICAL INC (NASDAQ:UTRS) have traded in today's session. Shares are falling by 25.02%. This is 113.0% above the average daily volume of the last 50 days. |
| GCT | -11.23% | 1.42M shares of GIGACLOUD TECHNOLOGY INC - A (NASDAQ:GCT) exchanged hands today. NASDAQ:GCT is declining 11.23% today. This is 83.34% above the average daily volume of the last 50 days. A press release (GigaCloud Technology Inc Announces First Quarter 2023 Financial Results, Reaching Highest Profitability in the Company’s History) was released yesterday. |
| OCEA | 13.55% | OCEAN BIOMEDICAL INC (NASDAQ:OCEA) has an unusual volume of 4.25M shares today. NASDAQ:OCEA is advancing 13.55% today. This volume is 169.0% above the average 50 day volume. |
| RAIN | -10.08% | 3.36M shares of RAIN ONCOLOGY INC (NASDAQ:RAIN) have been traded so far today. The share price decreased by 10.08%. The average daily volume over 50 days is 1.1M, so this is 205.0% above the average volume. |
| QUBT | -7.32% | 1.64M shares of QUANTUM COMPUTING INC (NASDAQ:QUBT) have been traded so far today. Shares are falling by 7.32%. The average daily volume over 50 days is 784.23K, so this is 109.0% above the average volume. |
| AUVI | -12.14% | 426.19K shares of APPLIED UV INC (NASDAQ:AUVI) have been traded so far today. NASDAQ:AUVI is declining 12.14% today. The average volume measured over 50 days is 313.85K, so this is 35.8% above the average volume. |
| APGN | -7.71% | APEXIGEN INC's (NASDAQ:APGN) traded a high volume of 678.79K shares. Shares are falling by 7.71%. The average daily volume over 50 days is 290.09K, so this is 134.0% above the average volume. A press release (APGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Apexigen, Inc. Is Fair to Shareholders) was released yesterday. |
| QBTS | 2.73% | 8.54M shares of D-WAVE QUANTUM INC (NYSE:QBTS) have been traded so far today. NYSE:QBTS is advancing 2.73% today. This volume is 242.0% above the average 50 day volume. |
| NAVB | -19.62% | So far 11.19M shares of NAVIDEA BIOPHARMACEUTICALS I (NYSEARCA:NAVB) have traded in today's session. The share price decreased by 19.62%. The average daily volume over 50 days is 1.72M, so this is 551.0% above the average volume. |
| TTOO | -4.26% | 13.26M shares of T2 BIOSYSTEMS INC (NASDAQ:TTOO) exchanged hands today. Shares are falling by 4.26%. The average volume measured over 50 days is 1.51M, so this is 780.0% above the average volume. |
To see the full list of unusual volume stocks you can use our unusual volume stocks screener.
NAVIDEA BIOPHARMACEUTICALS I
NYSEARCA:NAVB (5/25/2023, 11:54:38 AM)
0.1043
-0.03 (-19.77%)
NAVB News
11 minutes ago - ChartmillUnusual volume stocks in Thursday's sessionLet's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.
20 hours ago - ChartmillWhich stocks are moving after the closing bell on Wednesday?The US market regular session of Wednesday is over, let's have a look at the top gainers and losers in the after hours session today.
2 days ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayWe're starting off the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on Tuesday!
3 days ago - Navidea Biopharmaceuticals, Inc.Navidea Biopharmaceuticals, Inc. Investors Purchase $1.1 Million in Preferred Shares at Market
14 days ago - Seeking AlphaNavidea promotes Michael Sherman Blue to CMO post (NYSE:NAVB)Navidea Biopharmaceuticals (NAVB) said Thursday it promoted Michael Sherman Blue to the position of chief medical officer.
14 days ago - Navidea Biopharmaceuticals, Inc.Navidea Biopharmaceuticals, Inc. Promotes Michael Sherman Blue, M.D., FACEP, to Chief Medical Officer
17 days ago - Navidea Biopharmaceuticals, Inc.Navidea Biopharmaceuticals, Inc. Drives Strategy Forward, Shifts Approach for Communications
a month ago - Navidea Biopharmaceuticals, Inc.Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
a month ago - Navidea Biopharmaceuticals, Inc.Navidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694
2 months ago - Navidea Biopharmaceuticals, Inc.Navidea Biopharmaceuticals, Inc. Hires G2G Ventures as Executive Consultants; Chief Medical Officer Steps Down
2 months ago - Navidea Biopharmaceuticals, Inc.Navidea Biopharmaceuticals Reports Fourth Quarter 2022 Financial Results
2 months ago - Navidea Biopharmaceuticals, Inc.Navidea Biopharmaceuticals to Host Fourth Quarter 2022 Earnings Conference Call and Business Update
